Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines

Canadian Journal of Microbiology

Volumn 50, Issue 5, 2004, Pages 375-381

  Abdi Ali, A ^a   Worobec, E A ^b   Deezagi, A ^c   Malekzadeh, F ^d  

^a ALZAHRA UNIVERSITY   (Iran)

^b UNIVERSITY OF MANITOBA   (Canada)

^c NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Cytotoxicity; MTT assay; Pseudomonas aeruginosa; Pyocin

Indexed keywords

BACTERIA; CELLS; CHROMATOGRAPHIC ANALYSIS; ION EXCHANGE; POLYSACCHARIDES; TOXICITY; TUMORS;

CELL GROWTH; CLINICAL SOURCES; CYTOTOXICITY; ION EXCHANGE CHROMATOGRAPHY;

MICROBIOLOGY;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMMONIUM SULFATE; BACTERIOCIN; LIPOPOLYSACCHARIDE; MITOMYCIN C; PROTEINASE; PYOCIN; PYOCIN S2; SEPHAROSE; SODIUM DIHYDROGEN PHOSPHATE; UNCLASSIFIED DRUG;

MICROBIOLOGY;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANCER INHIBITION; CELL GROWTH; CELL LYSATE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; PSEUDOMONAS AERUGINOSA; PURIFICATION; TOXIN SYNTHESIS; TUMOR CELL LINE;

CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTOXINS; FORMAZANS; HUMANS; MITOMYCIN; MOLECULAR WEIGHT; NUCLEIC ACID SYNTHESIS INHIBITORS; PSEUDOMONAS AERUGINOSA; PYOCINS; TETRAZOLIUM SALTS;

BACTERIA (MICROORGANISMS); IRANIA; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 3442890260     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/w04-019     Document Type: Article

References (34)

1. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
2. Braun, V., Hancock, R.E.W., Hantkle, K., and Hartman, A. 1976. Functional organization of the outer membrane of E. coli: phage and colicin receptors as components of iron uptake systems. J. Supramol. Struct. 5: 37-58.
3. Brown, J.P., Hewick, R.M., Hellstrom, I., Heistrom, K.E., Doolittle, R.F., and Dreyer, W.J. 1982. Human melanoma-associated antigen-P97 is structurally and functionally related to transferring. Nature, 296: 171-173.
4. Carmichael, J., Degraff, W.G., Gazdar, A.F., Minna, J.D., and Mitchell, J.B. 1987. Evaluation of a tetrazolium based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47: 936-943.
5. Chen, D.C.P., Newman, B., Turkall, R.M., and Tsan, M.F. 1982. Transferrin receptors and GA-67. Eur. J. Nucl. Med. 7: 536-540.
6. Duport, C., Baysse, C., and Michel-Briand, Y. 1995. Molecular characterization of pyocin S3, a novel S-type pyocin from P. aeruginosa. J. Biol. Chem. 270: 8920-8927.
7. Farkas-Himsley, H. 1980. Sensitivity to bacteriocin of murine leukemias with varying oncogenic potency. Microbios Lett. 15: 89-96.
8. Farkas-Himsley, H. 1988. Sensitivity of various malignant cell lines to partially purified bacteriocins. Microbios Lett. 39: 57-66.
9. Farkas-Himsley, H., and Cheung, R. 1976. Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia. Cancer Res. 36: 3561-3567.
10. Farkas-Himsley, H., and Henry, Y. 1985. Purified colicin as cytotoxic agent of neoplasia: comparative study with crude colicin. Cytobios, 42: 193-203.
11. Farkas-Himsley, H., and Musclow, C.E. 1986. Bacteriocin receptors on malignant mammalian cells: are they transferring receptors? Cell. Mol. Biol. 32: 607-617.
12. Farkas-Himsley, H., Freedman, F., Read, S.E., Asad, S., and Kardish, M. 1991. Bacterial proteins cytotoxic to HIV-1 infected cells. AIDS, 5: 905-907.
13. Farkas-Himsley, H., Zhang, Y.S., and Musclow, C.E. 1992. Partially purified bacteriocin kills malignant cells by apoptosis. Cell. Mol. Biol. 38: 643-651.
14. Farkas-Himsley, H., Hill, R., Rosen, B., Arab, S., and Lingwood, C. 1995. The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin. Proc. Natl. Acad. Sci. USA. 92: 6996-7000.
15. Fumarola, D. 1977. Bacteriocins as cytotoxic agents: the role of possible contaminants. IRCS Med. Sci. 5: 596.
16. Fyfe, J.A.M., Harris, G., and Govan, J.R.W. 1984. Revised pyocin typing method for P. aeruginosa. J. Clin. Microbiol. 20: 47-50.
17. Gatter, K.C., Brown, G., Trowbridge, I., Woolston, R., and Mason, D.Y. 1983. Transferrin receptors in human tissue: their distribution and possible clinical relevance. J. Clin. Pathol. 36: 539-545.
18. Govan, J.R.W. 1974. Studies on the pyocins of P. aeruginosa: morphology and mode of action of contractile pyocins. J. Gen. Microbiol. 80: 1-15.
19. Higerd, T.B., Barchler, C.A., and Berk, S. 1967. In vitro and in vivo characterization of pyocin. J. Bacteriol. 93: 1976-1986.
20. Hill, R.R., and Farkas-Himsley, H. 1991. Further studies of the action of partially purified bacteriocin against a mucin fibrosarcoma. Cancer Res. 51: 1359-1365.
21. Ito, S., Kageyama, M., and Egami, F. 1970. Isolation and characterization of pyocin from several strains of P. aeruginosa. J. Gen. Appl. Microbiol. 16: 205-214.
22. Kageyama, M. 1964. Studies of a pyocin. I. Physical and chemical properties. J. Biochem. (Tokyo), 55: 49-53.
23. Kurodo, K., and Kageyama, M. 1979. Biochemical properties of a new flexuous bacteriocin pyocin F1, produced by P. aeruginosa. J. Biochem. (Tokyo), 78: 7-19.
24. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London), 227: 680-685.
25. Matsui, H., Sano, Y., Ishihara, H., and Shinomiya, T. 1993. Regulation of pyocin genes in P. aeruginosa by positive (prtN) and negative (prtR) regulatory genes. J. Bacteriol. 175: 1257-1263.
26. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63.
27. Ohkawa, I., Kageyama, M., and Egarai, F. 1973. Purification and properties of pyocin S2. J. Biochem. 73: 281-289.
28. Ohkawa, I., Shiga, S., and Kageyama, M. 1980. Effect of iron concentration in the growth medium on the sensitivity of P. aeruginosa to pyocin S2. J. Biochem. (Tokyo), 87: 323-331.
29. Parret, A., and De-Met, R. 2000. Novel bacteriocin with predicted tRNase and pore forming activities in P. aeruginosa PAO1. Mol. Microbiol. 35: 472-475.
30. Sano, Y., and Kageyama, M. 1981. Purification and properties of an S type pyocin, Pyocin AP41. J. Bacteriol. 146: 733-739.
31. Sano, Y., and Kageyama, M. 1984. Genetic determinant of Pyocin AP41 as an insert in the P. aeruginosa chromosome. J. Bacteriol. 158: 562-570.
32. Sano, Y., and Kageyama, M. 1993. A novel transposon like structure carries the genes for Pyocin AP41, a P. aeruginosa bacteriocin with a DNase domain homology to E2 group colicins. Mol. Gen. Genet. 237: 161-170.
33. Sano, Y., Matsui, H., Kobayashi, M., and Kageyama, M. 1993. Molecular structure and functions of Pyocin S1 and S2 in P. aeruginosa. J. Bacteriol. 175: 2907-2916.
34. Seo, Y., and Galloway, D.R. 1990. Purification of the pyocin S2 complex from P. aeruginosa PAO1. Biochem. Biophys. Res. Comm. 172: 455-461.